止血剂市场规模、份额和成长分析：按产品类型、应用领域、最终用户、分销管道和地区划分 - 2026-2033 年行业预测

2024年全球止血剂市场价值为8.564亿美元，预计将从2025年的9.1977亿美元成长到2033年的16.2823亿美元。预测期（2026-2033年）的复合年增长率预计为7.4%。

全球辅助止血剂市场的主要驱动力是外科手术日益复杂化以及对有效止血方案日益增长的需求。这些止血剂（包括局部用药、贴片和密封剂）对于复杂手术中控制非压迫性出血至关重要，尤其是在心血管外科和肿瘤外科领域。技术创新推动了止血剂从基础材料向先进的明胶-凝血酶基质和生物密封剂的演变，提高了其疗效和安全性。随机对照试验和真实世界临床研究的证据表明，这些止血剂能够减少出血併发症并缩短手术时间，这进一步推动了医院的采购。此外，人工智慧 (AI) 在产品开发中的应用加速了材料的发现，透过针对外科医生需求的功能性设计加快了设计流程，最终促进了止血剂在各种手术环境中的推广应用和商业性应用。

全球止血剂市场驱动因素

随着全球外科手术数量的增加，对辅助性止血剂的需求也急剧上升。医疗专业人员和手术团队需要有效的工具来实现快速止血、最大限度地减少术中出血并改善围手术全期整体预后。随着复杂微创手术的日益普及，辅助止血剂的临床益处正被更广泛地认可，加速了医院和外科医生将这些产品作为标准治疗方法的采用。这种广泛的认可促使采购量增加，并被纳入药品目录，从而促进了常规使用。这不仅扩大了市场应用，也鼓励对产品供应链和分销网络进行持续投资。

全球止血剂市场限制因素

全球辅助止血剂市场面临许多挑战，例如特定产品的采购成本不断上涨以及医保报销政策的不一致，这些都会影响医院的采购决策。在医疗成本控制日益严格的环境下，由于缺乏明确的支付方支持，采购委员会往往优先考虑成本较低的替代方案和标准做法。这种抵抗情绪阻碍了辅助止血剂的频繁使用，并延缓了其在临床通讯协定中的应用。因此，儘管临床获益使其具有更高的使用潜力，但由于重复购买率下降和市场渗透率有限，市场成长受到抑制。

全球止血剂市场趋势

受微创外科技术广泛应用的推动，全球辅助止血剂市场正经历重大变革时期。随着外科手术技术的进步，人们对能够在狭小空间内提供卓越止血效果、快速控制出血并能适应复杂解剖结构的止血剂的需求日益增长。这一趋势推动了稀薄、液态和喷雾型止血剂以及专用施用器的研发，这些涂抹器能够与先进的手术器械无缝整合。製造商正在改进产品包装、提供培训解决方案并优化相容性，以满足外科医生的需求。预计这将促进止血剂在各个外科专科领域的更广泛应用。

目录

介绍

• 调查目的
• 市场定义和范围

调查方法

• 研究过程
• 二级资料和一级资料的方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争环境概述

市场动态及展望

• 总体经济指标
• 促进者和机会
• 抑制因素和挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

市场考察

• 关键成功因素
• 影响市场的因素
• 主要投资机会
• 生态系图谱
• 2025年市场吸引力指数
• PESTEL 分析
• 监理情势

全球止血剂市场规模：依产品类型及复合年增长率（2026-2033 年）划分

• 凝胶型止血剂
• 泡沫型止血剂
• 纤维基止血剂

全球止血剂市场规模：按应用和复合年增长率划分（2026-2033 年）

• 外科手术
  • 整形外科手术
  • 心血管外科
• 创伤病例

全球止血剂市场规模：依最终用户和复合年增长率划分（2026-2033 年）

• 医院
• 门诊手术中心
• 诊所

全球止血剂市场规模：按分销管道和复合年增长率划分（2026-2033 年）

• 直销
• 线上销售
• 销售代理

全球止血剂市场规模及复合年增长率（2026-2033）

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场公司采取的策略
• 近期市场趋势
• 企业市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 按细分市场进行企业市占率分析
  • 2023-2025年营收年比比较

主要企业简介

• Johnson & Johnson
• Baxter International
• Medtronic
• CR Bard
• Ethicon
• Integra LifeSciences
• Stryker Corporation
• ZymoGenetics
• Hemostasis LLC
• Anika Therapeutics
• Acelity
• Tissuemed
• CryoLife
• Plexus Biomedical
• Biometrix
• Cohera Medical
• Revive Surgical
• Haemostatic Technologies
• Arthrex
• Sientra

结论与建议

Global Adjunctive Hemostats Market size was valued at USD 856.4 Million in 2024 and is poised to grow from USD 919.77 Million in 2025 to USD 1628.23 Million by 2033, growing at a CAGR of 7.4% during the forecast period (2026-2033).

The Global Adjunctive Hemostats Market is primarily driven by the increasing complexity of surgical procedures and the growing demand for effective bleeding control solutions. These hemostatic agents, including topical applications, patches, and sealants, are crucial in managing non-compressible bleeding during intricate surgeries, particularly in cardiovascular and oncologic contexts. Innovations have evolved from basic materials to advanced gelatin-thrombin matrices and biological sealants, enhancing their efficacy and safety. Evidence from randomized trials and real-world studies showcasing reduced bleeding complications and shorter operation times further propel hospital procurement. Additionally, the integration of artificial intelligence (AI) in product development enhances material discovery and accelerates the design process by tailoring features to surgeon needs, ultimately facilitating easier adoption and commercial opportunities across diverse surgical settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Adjunctive Hemostats market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Adjunctive Hemostats Market Segments Analysis

Global adjunctive hemostats market is segmented by product type, application area, end user, distribution channel and region. Based on product type, the market is segmented into Gel-based Hemostats, Foam-based Hemostats and Fiber-based Hemostats. Based on application area, the market is segmented into Surgical Procedures and Trauma Cases. Based on end user, the market is segmented into Hospitals, Ambulatory Surgery Centers and Clinics. Based on distribution channel, the market is segmented into Direct Sales, Online Sales and Distributors. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Adjunctive Hemostats Market

The growing volume of surgical procedures worldwide significantly boosts the demand for adjunctive hemostats, as healthcare professionals and surgical teams require effective tools to attain swift hemostasis, minimize intraoperative bleeding, and enhance overall perioperative results. With the increasing prevalence of complex and minimally invasive surgeries, the clinical advantages of adjunctive hemostats are becoming more recognized, prompting hospitals and surgeons to adopt these products into standard care practices. This widespread acceptance leads to greater procurement and formulary inclusion, resulting in routine usage that not only broadens market adoption but also encourages ongoing investment in product availability and distribution networks.

Restraints in the Global Adjunctive Hemostats Market

The Global Adjunctive Hemostats market faces challenges due to elevated acquisition costs for specific products and inconsistent reimbursement policies that affect purchasing decisions within hospitals. In cost-sensitive healthcare environments, lack of clear support from payers for additional product expenses leads procurement committees to favor lower-cost alternatives or standard practices. This reluctance hinders the frequent use of adjunctive hemostats and slows their integration into clinical protocols. Consequently, the market growth is impeded as repeat purchases wane and broader market penetration is restricted, despite the potential clinical benefits that could drive increased utilization.

Market Trends of the Global Adjunctive Hemostats Market

The Global Adjunctive Hemostats market is experiencing a significant shift driven by the increasing adoption of minimally invasive surgical techniques. As surgical practices evolve, there is a growing demand for hemostatic agents that excel in constrained environments, offering rapid bleeding control and the ability to adapt to complex anatomical structures. This trend is propelling the development of low-profile, flowable, and sprayable hemostats, along with specialized applicators designed for seamless integration with advanced surgical instruments. Manufacturers are enhancing product packaging, providing training solutions, and optimizing compatibility to align with surgeon preferences, ultimately facilitating broader acceptance and application across diverse surgical specialties.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Adjunctive Hemostats Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Gel-based Hemostats
• Foam-based Hemostats
• Fiber-based Hemostats

Global Adjunctive Hemostats Market Size by Application Area & CAGR (2026-2033)

• Market Overview
• Surgical Procedures
  • Orthopedic Surgeries
  • Cardiovascular Surgeries
• Trauma Cases

Global Adjunctive Hemostats Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgery Centers
• Clinics

Global Adjunctive Hemostats Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Online Sales
• Distributors

Global Adjunctive Hemostats Market Size & CAGR (2026-2033)

• North America (Product Type, Application Area, End User, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Application Area, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application Area, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application Area, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application Area, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C.R. Bard
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ethicon
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZymoGenetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemostasis LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anika Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acelity
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tissuemed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Plexus Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biometrix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohera Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revive Surgical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemostatic Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sientra
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations